Concepedia

Shengfang Jin

SJ

Statistics

Publications

24

Citations

9.3K

H-Index

22

Active since

1996

Affiliations

Agios Pharmaceuticals (United States)(Current)

Harvard University

Dana-Farber Cancer Institute

Institut Gustave Roussy

Shengfang Jin is an author at Agios Pharmaceuticals (United States) specializing in molecular oncology, life sciences, and molecular biology.

Publications per year

1996–2019

24

Publications

24

Cancer-associated IDH1 mutations produce 2-hydroxyglutarate

Lenny Dang, David W. White, Bryson D. Bennett et al. · Nature · 2009 · 4.1K citations · Full text

Medicine, Genetics, Molecular Genetics +10

Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis

Dimitrios Anastasiou, Yimin Yu, William J. Israelsen et al. · Nature Chemical Biology · 2012 · 825 citations · Full text

Life Sciences, Cancer Biology, Molecular Biology +15

Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutations

Rob A. Cairns, Mark D. Minden, Edward M. Driggers et al. · The Journal of Experimental Medicine · 2010 · 727 citations · Full text

Life Sciences, Biochemistry, Oncology +17

Cancer-associated IDH1 mutations produce 2-hydroxyglutarate

Lenny Dang, David W. White, Bryson D. Bennett et al. · Nature · 2010 · 596 citations

Medicine, Genetics, Molecular Genetics +10

AG-221, a First-in-Class Therapy Targeting Acute Myeloid Leukemia Harboring Oncogenic <i>IDH2</i> Mutations

Katharine Yen, Jeremy Travins, Fang Wang et al. · Cancer Discovery · 2017 · 458 citations · Full text

Medicine, Oncology, Pharmacology +17

1–5 of 24